Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Paragon Biosciences
Chicago, Illinois, United Statesparagonbiosci.com ↗
- Ownership
- Private
- Employees
- ~27
- Development stage
- Other
01
Overview
Paragon Biosciences is a global life science leader that creates, builds, and funds innovative biology-based companies. The company has a portfolio of independently-run bioscience companies focusing on biopharmaceuticals, AI-enabled life science products, and advanced treatments. One of its portfolio companies, Harmony Biosciences, has successfully commercialized the first nonscheduled treatment for narcolepsy[1][3].
- Therapeutic areas
- DermatologyOphthalmologyNeurology
- Modalities
- Gene therapiescell therapiesprotein therapeuticssmall molecules
- Industry
- Investors
02
Partnerships
Blackstone (NYSE: BX)
Beyond the preview
Go deeper on Paragon Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Paragon Biosciences.